OverviewChartNewsTraderScreen

Morgan Stanley Call 730 LLY 20.06.../  DE000ME8QSQ6  /

Stuttgart
2024-09-05  9:28:02 AM Chg.0.00 Bid12:58:29 PM Ask12:58:29 PM Underlying Strike price Expiration date Option type
3.94EUR 0.00% 3.93
Bid Size: 5,000		 3.99
Ask Size: 5,000		 ELI LILLY 730.00 - 2025-06-20 Call
GlobeNewswire 09-03 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
Newsfile Corp 08-28 The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire 08-27 Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership...
GlobeNewswire 08-26 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 08-21 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 08-21 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 08-19 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 08-14 Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s ...
GlobeNewswire 08-14 Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD...
TeleTrader 08-09 US trades up premarket after yesterday's earnings
TeleTrader 08-08 Wall Street rallies at close, Dow soars 680 pts
GlobeNewswire 08-08 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
TeleTrader 08-08 US opens higher with data, earnings in focus
GlobeNewswire 08-08 ProQR Announces Second Quarter 2024 Operating and Financial Results
TeleTrader 08-08 Eli Lilly's Q2 revenue jumps 36% to $11.3B
GlobeNewswire 08-08 Defiance Launches LLYX, the First 2X Leveraged Single-Stock ETF on Eli Lilly
TeleTrader 08-08 US down premarket as volatility persists
GlobeNewswire 08-07 Pattern Announces Company Presentation at LSX World Congress USA
GlobeNewswire 08-06 Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire 08-06 SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discov...
GlobeNewswire 08-02 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
GlobeNewswire 08-01 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 08-01 COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives
GlobeNewswire 07-31 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders
GlobeNewswire 07-31 MORF Alert: Wohl & Fruchter LLP Files Class Action Lawsuit on Behalf of Shareholders of Morphic Hold...